What Researchers Did
Researchers retrospectively analyzed clinical data from 78 patients with necrotizing soft tissue infections (NSTIs) to compare outcomes between those receiving standard care alone and those receiving standard care with adjunctive hyperbaric oxygen (HBO) treatment.
What They Found
The study included 78 patients with a mean age of 49.5 years; 37% were female, and 49% had diabetes mellitus. Patients underwent a mean of 3.0 debridements, with a median hospital stay of 16.5 days and median antibiotic use of 15.0 days. The mortality rate for the HBO group was 8.3%, which was not statistically significantly different from the non-HBO group (p = 0.48).
What This Means for Canadian Patients
Canadian patients with necrotizing soft tissue infections may not see improved outcomes with adjunctive hyperbaric oxygen therapy based on these findings. Treatment should continue to prioritize prompt surgical debridement, appropriate antibiotics, and intensive supportive care.
Canadian Relevance
This study has no direct Canadian connection, as it was conducted in the United States.
Study Limitations
The study's retrospective design and data collection from two different centers introduce potential for selection bias and limit the generalizability of the findings.